Last 12 months
Inside the activity.
0 purchase rows · 93 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 6 |
| Dec 2025 | 0 | 16 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 49 |
| Mar 2026 | 0 | 5 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 6 |
| Jun 2026 | 0 | 5 |
| Jul 2026 | 0 | 3 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 03, 2016 Filed Feb 4, 2016 23:51 UTC |
Arbuckle Stuart AEVP\Chief Commercial Officer
|
SaleCommon Stock | 2,100 | $90.98 | $191,058.00 |
DisclosureSEC source: 0001209191-16-095840 · doc4.xml · nonDerivative · entry 3 Arbuckle Stuart A · CIK 0001557290 · EVP\Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,066 F1 · kind: Transaction made pursuant to Mr. Arbuckle's company approved trading plan under Rule 10b5-1. F3 · price: Mr. Arbuckle undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F4 · price: Open market sales reported on this line occurred at a weighted average price of $90.98 (range $90.38 to $91.32). Read SEC document |
| February 03, 2016 Filed Feb 4, 2016 23:51 UTC |
Arbuckle Stuart AEVP\Chief Commercial Officer
|
SaleCommon Stock | 2,597 | $89.92 | $233,522.24 |
DisclosureSEC source: 0001209191-16-095840 · doc4.xml · nonDerivative · entry 2 Arbuckle Stuart A · CIK 0001557290 · EVP\Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,166 F1 · kind: Transaction made pursuant to Mr. Arbuckle's company approved trading plan under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $89.92 (range $89.31 to $90.27). F3 · price: Mr. Arbuckle undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| February 03, 2016 Filed Feb 4, 2016 23:52 UTC |
LEIDEN JEFFREY MDirector · CEO & President
|
SaleCommon Stock | 1,034 | $92.87 | $96,027.58 |
DisclosureSEC source: 0001209191-16-095842 · doc4.xml · nonDerivative · entry 5 LEIDEN JEFFREY M · CIK 0001242825 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 261,885 F2 · kind: Transaction made pursuant to Dr. Leiden's company approved trading plan under Rule 10b5-1. F4 · price: Dr. Leiden undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F7 · price: Open market sales reported on this line occurred at a weighted average price of $92.87 (range $92.50 to $93.11). Read SEC document |
| February 03, 2016 Filed Feb 4, 2016 23:52 UTC |
LEIDEN JEFFREY MDirector · CEO & President
|
SaleCommon Stock | 900 | $91.96 | $82,764.00 |
DisclosureSEC source: 0001209191-16-095842 · doc4.xml · nonDerivative · entry 4 LEIDEN JEFFREY M · CIK 0001242825 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 262,919 F2 · kind: Transaction made pursuant to Dr. Leiden's company approved trading plan under Rule 10b5-1. F4 · price: Dr. Leiden undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F6 · price: Open market sales reported on this line occurred at a weighted average price of $91.96 (range $91.40 to $92.37). Read SEC document |
| February 03, 2016 Filed Feb 4, 2016 23:52 UTC |
LEIDEN JEFFREY MDirector · CEO & President
|
SaleCommon Stock | 3,700 | $91.01 | $336,737.00 |
DisclosureSEC source: 0001209191-16-095842 · doc4.xml · nonDerivative · entry 3 LEIDEN JEFFREY M · CIK 0001242825 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 263,819 F2 · kind: Transaction made pursuant to Dr. Leiden's company approved trading plan under Rule 10b5-1. F4 · price: Dr. Leiden undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F5 · price: Open market sales reported on this line occurred at a weighted average price of $91.01 (range $90.37 to $91.33). Read SEC document |
| February 03, 2016 Filed Feb 4, 2016 23:52 UTC |
LEIDEN JEFFREY MDirector · CEO & President
|
SaleCommon Stock | 4,200 | $89.91 | $377,622.00 |
DisclosureSEC source: 0001209191-16-095842 · doc4.xml · nonDerivative · entry 2 LEIDEN JEFFREY M · CIK 0001242825 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 267,519 F2 · kind: Transaction made pursuant to Dr. Leiden's company approved trading plan under Rule 10b5-1. F3 · price: Open market sales reported on this line occurred at a weighted average price of $89.91 (range $89.31 to $90.27). F4 · price: Dr. Leiden undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| February 03, 2016 Filed Feb 4, 2016 23:52 UTC |
Sachdev AmitEVP, Policy, Access & Value
|
SaleCommon Stock | 1,266 | $92.79 | $117,472.14 |
DisclosureSEC source: 0001209191-16-095843 · doc4.xml · nonDerivative · entry 5 Sachdev Amit · CIK 0001406338 · EVP, Policy, Access & Value 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,096 F2 · kind: Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1. F4 · price: Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F7 · price: Open market sales reported on this line occurred at a weighted average price of $92.79 (range $92.42 to $93.11). Read SEC document |
| February 03, 2016 Filed Feb 4, 2016 23:52 UTC |
Sachdev AmitEVP, Policy, Access & Value
|
SaleCommon Stock | 900 | $91.82 | $82,638.00 |
DisclosureSEC source: 0001209191-16-095843 · doc4.xml · nonDerivative · entry 4 Sachdev Amit · CIK 0001406338 · EVP, Policy, Access & Value 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,362 F2 · kind: Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1. F4 · price: Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F6 · price: Open market sales reported on this line occurred at a weighted average price of $91.82 (range $91.37 to $92.26). Read SEC document |
| February 03, 2016 Filed Feb 4, 2016 23:52 UTC |
Sachdev AmitEVP, Policy, Access & Value
|
SaleCommon Stock | 3,700 | $91.01 | $336,737.00 |
DisclosureSEC source: 0001209191-16-095843 · doc4.xml · nonDerivative · entry 3 Sachdev Amit · CIK 0001406338 · EVP, Policy, Access & Value 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,262 F2 · kind: Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1. F4 · price: Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F5 · price: Open market sales reported on this line occurred at a weighted average price of $91.01 (range $90.37 to $91.35). Read SEC document |
| February 03, 2016 Filed Feb 4, 2016 23:52 UTC |
Sachdev AmitEVP, Policy, Access & Value
|
SaleCommon Stock | 4,300 | $89.91 | $386,613.00 |
DisclosureSEC source: 0001209191-16-095843 · doc4.xml · nonDerivative · entry 2 Sachdev Amit · CIK 0001406338 · EVP, Policy, Access & Value 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,962 F2 · kind: Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1. F3 · price: Open market sales reported on this line occurred at a weighted average price of $89.91 (range $89.31 to $90.27). F4 · price: Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| February 03, 2016 Filed Feb 4, 2016 23:53 UTC |
Silva Paul MSVP & Corp Controller
|
SaleCommon Stock | 200 | $93.06 | $18,612.00 |
DisclosureSEC source: 0001209191-16-095844 · doc4.xml · nonDerivative · entry 5 Silva Paul M · CIK 0001446372 · SVP & Corp Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,750 F2 · kind: Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1. F4 · price: Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F7 · price: Open market sales reported on this line occurred at a weighted average price of $93.06 (range $92.98 to $93.14). Read SEC document |
| February 03, 2016 Filed Feb 4, 2016 23:53 UTC |
Silva Paul MSVP & Corp Controller
|
SaleCommon Stock | 662 | $92.43 | $61,188.66 |
DisclosureSEC source: 0001209191-16-095844 · doc4.xml · nonDerivative · entry 4 Silva Paul M · CIK 0001446372 · SVP & Corp Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,950 F2 · kind: Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1. F4 · price: Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F6 · price: Open market sales reported on this line occurred at a weighted average price of $92.43 (range $91.79 to $92.72). Read SEC document |
| February 03, 2016 Filed Feb 4, 2016 23:53 UTC |
Silva Paul MSVP & Corp Controller
|
SaleCommon Stock | 1,900 | $91.07 | $173,033.00 |
DisclosureSEC source: 0001209191-16-095844 · doc4.xml · nonDerivative · entry 3 Silva Paul M · CIK 0001446372 · SVP & Corp Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,612 F2 · kind: Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1. F4 · price: Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F5 · price: Open market sales reported on this line occurred at a weighted average price of $91.07 (range $90.56 to $91.48). Read SEC document |
| February 03, 2016 Filed Feb 4, 2016 23:53 UTC |
Silva Paul MSVP & Corp Controller
|
SaleCommon Stock | 2,300 | $89.96 | $206,908.00 |
DisclosureSEC source: 0001209191-16-095844 · doc4.xml · nonDerivative · entry 2 Silva Paul M · CIK 0001446372 · SVP & Corp Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,512 F2 · kind: Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1. F3 · price: Open market sales reported on this line occurred at a weighted average price of $89.96 (range $89.54 to $90.44). F4 · price: Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| February 03, 2016 Filed Feb 4, 2016 23:54 UTC |
SMITH IAN FEVP & CFO
|
SaleCommon Stock | 1,652 | $92.73 | $153,189.96 |
DisclosureSEC source: 0001209191-16-095845 · doc4.xml · nonDerivative · entry 5 SMITH IAN F · CIK 0001197032 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,999 F2 · kind: Transaction made pursuant to Mr. Smith's company approved trading plan under Rule 10b5-1. F4 · price: Mr. Smith undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F7 · price: Open market sales reported on this line occurred at a weighted average price of $92.73 (range $92.34 to $93.20). Read SEC document |
| February 03, 2016 Filed Feb 4, 2016 23:54 UTC |
SMITH IAN FEVP & CFO
|
SaleCommon Stock | 1,200 | $91.68 | $110,016.00 |
DisclosureSEC source: 0001209191-16-095845 · doc4.xml · nonDerivative · entry 4 SMITH IAN F · CIK 0001197032 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,651 F2 · kind: Transaction made pursuant to Mr. Smith's company approved trading plan under Rule 10b5-1. F4 · price: Mr. Smith undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F6 · price: Open market sales reported on this line occurred at a weighted average price of $91.68 (range $91.33 to $92.23). Read SEC document |
| February 03, 2016 Filed Feb 4, 2016 23:54 UTC |
SMITH IAN FEVP & CFO
|
SaleCommon Stock | 4,232 | $90.97 | $384,985.04 |
DisclosureSEC source: 0001209191-16-095845 · doc4.xml · nonDerivative · entry 3 SMITH IAN F · CIK 0001197032 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,851 F2 · kind: Transaction made pursuant to Mr. Smith's company approved trading plan under Rule 10b5-1. F4 · price: Mr. Smith undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F5 · price: Open market sales reported on this line occurred at a weighted average price of $90.97 (range $90.32 to $91.30). Read SEC document |
| February 03, 2016 Filed Feb 4, 2016 23:54 UTC |
SMITH IAN FEVP & CFO
|
SaleCommon Stock | 5,000 | $89.90 | $449,500.00 |
DisclosureSEC source: 0001209191-16-095845 · doc4.xml · nonDerivative · entry 2 SMITH IAN F · CIK 0001197032 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,083 F2 · kind: Transaction made pursuant to Mr. Smith's company approved trading plan under Rule 10b5-1. F3 · price: Open market sales reported on this line occurred at a weighted average price of $89.90 (range $89.31 to $90.27). F4 · price: Mr. Smith undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| February 03, 2016 Filed Feb 5, 2016 20:12 UTC |
BOGER JOSHUA SDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,130 | $0.00 Strike: $35.35 | $0.00 |
DisclosureSEC source: 0001209191-16-095962 · doc4.xml · derivative · entry 11 BOGER JOSHUA S · CIK 0001197023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,870 Underlying: Common Stock · 5,130 shares Expires 2016-07-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · derivative.exercise_date: Fully vested. Read SEC document |
| February 03, 2016 Filed Feb 5, 2016 20:12 UTC |
BOGER JOSHUA SDirector
|
SaleCommon Stock | 530 | $93.61 | $49,613.30 |
DisclosureSEC source: 0001209191-16-095962 · doc4.xml · nonDerivative · entry 8 BOGER JOSHUA S · CIK 0001197023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 265,284 F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1. F3 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F9 · price: Open market sales reported on this line occurred at a weighted average price of $93.61 (range $93.34 to $93.96). Read SEC document |
| February 03, 2016 Filed Feb 5, 2016 20:12 UTC |
BOGER JOSHUA SDirector
|
SaleCommon Stock | 800 | $92.94 | $74,352.00 |
DisclosureSEC source: 0001209191-16-095962 · doc4.xml · nonDerivative · entry 7 BOGER JOSHUA S · CIK 0001197023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 265,814 F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1. F3 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F8 · price: Open market sales reported on this line occurred at a weighted average price of $92.94 (range $92.32 to $93.15). Read SEC document |
| February 03, 2016 Filed Feb 5, 2016 20:12 UTC |
BOGER JOSHUA SDirector
|
SaleCommon Stock | 700 | $91.58 | $64,106.00 |
DisclosureSEC source: 0001209191-16-095962 · doc4.xml · nonDerivative · entry 6 BOGER JOSHUA S · CIK 0001197023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 266,614 F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1. F3 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F7 · price: Open market sales reported on this line occurred at a weighted average price of $91.58 (range $91.25 to $92.22). Read SEC document |
| February 03, 2016 Filed Feb 5, 2016 20:12 UTC |
BOGER JOSHUA SDirector
|
SaleCommon Stock | 1,300 | $90.63 | $117,819.00 |
DisclosureSEC source: 0001209191-16-095962 · doc4.xml · nonDerivative · entry 5 BOGER JOSHUA S · CIK 0001197023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 267,314 F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1. F3 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F6 · price: Open market sales reported on this line occurred at a weighted average price of $90.63 (range $90.20 to $91.07). Read SEC document |
| February 03, 2016 Filed Feb 5, 2016 20:12 UTC |
BOGER JOSHUA SDirector
|
SaleCommon Stock | 1,100 | $89.60 | $98,560.00 |
DisclosureSEC source: 0001209191-16-095962 · doc4.xml · nonDerivative · entry 4 BOGER JOSHUA S · CIK 0001197023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 268,614 F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1. F3 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F5 · price: Open market sales reported on this line occurred at a weighted average price of $89.60 (range $89.15 to $90.08). Read SEC document |
| February 03, 2016 Filed Feb 5, 2016 20:12 UTC |
BOGER JOSHUA SDirector
|
SaleCommon Stock | 500 | $88.11 | $44,055.00 |
DisclosureSEC source: 0001209191-16-095962 · doc4.xml · nonDerivative · entry 3 BOGER JOSHUA S · CIK 0001197023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 269,714 F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1. F3 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F4 · price: Open market sales reported on this line occurred at a weighted average price of $88.11(range $87.82 to $88.30). Read SEC document |
| February 03, 2016 Filed Feb 5, 2016 20:12 UTC |
BOGER JOSHUA SDirector
|
SaleCommon Stock | 200 | $86.66 | $17,332.00 |
DisclosureSEC source: 0001209191-16-095962 · doc4.xml · nonDerivative · entry 2 BOGER JOSHUA S · CIK 0001197023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 270,214 F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $86.66 (range $86.37 to $86.94). F3 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| February 03, 2016 Filed Feb 5, 2016 20:12 UTC |
BOGER JOSHUA SDirector
|
Exercise / conversionCommon Stock | 5,130 | $35.35 | $181,345.50 |
DisclosureSEC source: 0001209191-16-095962 · doc4.xml · nonDerivative · entry 1 BOGER JOSHUA S · CIK 0001197023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 270,414 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 02, 2016 Filed Feb 4, 2016 23:50 UTC |
ALTSHULER DAVIDEVP, Global Research and CSO
|
GrantStock Option (Right to Buy) · Derivative | 28,735 | $0.00 Strike: $91.05 | $0.00 |
DisclosureSEC source: 0001209191-16-095839 · doc4.xml · derivative · entry 2 ALTSHULER DAVID · CIK 0001550395 · EVP, Global Research and CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,735 Underlying: Common Stock · 28,735 shares Expires 2026-02-01 F2 · derivative.exercise_date: The option vests in 16 quarterly installments from 02/02/2016. Read SEC document |
| February 02, 2016 Filed Feb 4, 2016 23:50 UTC |
ALTSHULER DAVIDEVP, Global Research and CSO
|
GrantCommon Stock | 14,416 | $0.01 | $144.16 |
DisclosureSEC source: 0001209191-16-095839 · doc4.xml · nonDerivative · entry 1 ALTSHULER DAVID · CIK 0001550395 · EVP, Global Research and CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,416 F1 · shares: Restricted stock unit award that vests in three equal installments on 2/10/2017, 2/10/2018 and 2/10/2019. Read SEC document |
| February 02, 2016 Filed Feb 4, 2016 23:51 UTC |
Arbuckle Stuart AEVP\Chief Commercial Officer
|
GrantStock Option (Right to Buy) · Derivative | 34,482 | $0.00 Strike: $91.05 | $0.00 |
DisclosureSEC source: 0001209191-16-095840 · doc4.xml · derivative · entry 7 Arbuckle Stuart A · CIK 0001557290 · EVP\Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,482 Underlying: Common Stock · 34,482 shares Expires 2026-02-01 F7 · derivative.exercise_date: The option vests in 16 quarterly installments from 02/02/2016. Read SEC document |
| February 02, 2016 Filed Feb 4, 2016 23:51 UTC |
Arbuckle Stuart AEVP\Chief Commercial Officer
|
GrantCommon Stock | 17,299 | $0.01 | $172.99 |
DisclosureSEC source: 0001209191-16-095840 · doc4.xml · nonDerivative · entry 1 Arbuckle Stuart A · CIK 0001557290 · EVP\Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,763 Read SEC document |
| February 02, 2016 Filed Feb 4, 2016 23:51 UTC |
Chodakewitz JeffreyEVP GMDA, CMO
|
GrantCommon Stock · Derivative | 28,735 | $0.00 Strike: $91.05 | $0.00 |
DisclosureSEC source: 0001209191-16-095841 · doc4.xml · derivative · entry 4 Chodakewitz Jeffrey · CIK 0001610876 · EVP GMDA, CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,735 Underlying: Common Stock · 28,735 shares Expires 2026-02-01 F6 · derivative.exercise_date: The option vests in 16 quarterly installments from 02/02/2016. Read SEC document |
| February 02, 2016 Filed Feb 4, 2016 23:51 UTC |
Chodakewitz JeffreyEVP GMDA, CMO
|
SaleCommon Stock | 1,275 | $91.80 | $117,045.00 |
DisclosureSEC source: 0001209191-16-095841 · doc4.xml · nonDerivative · entry 3 Chodakewitz Jeffrey · CIK 0001610876 · EVP GMDA, CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,603 F2 · kind: Transaction made pursuant to Dr. Chodakewitz's company approved trading plan under Rule 10b5-1. F3 · price: Dr. Chodakewitz undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F5 · price: Open market sales reported on this line occurred at a weighted average price of $91.80 (range $91.56 to $92.36). Read SEC document |
| February 02, 2016 Filed Feb 4, 2016 23:51 UTC |
Chodakewitz JeffreyEVP GMDA, CMO
|
SaleCommon Stock | 1,100 | $90.89 | $99,979.00 |
DisclosureSEC source: 0001209191-16-095841 · doc4.xml · nonDerivative · entry 2 Chodakewitz Jeffrey · CIK 0001610876 · EVP GMDA, CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,878 F2 · kind: Transaction made pursuant to Dr. Chodakewitz's company approved trading plan under Rule 10b5-1. F3 · price: Dr. Chodakewitz undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F4 · price: Open market sales reported on this line occurred at a weighted average price of $90.89 (range $90.49 to $91.33). Read SEC document |
| February 02, 2016 Filed Feb 4, 2016 23:51 UTC |
Chodakewitz JeffreyEVP GMDA, CMO
|
GrantCommon Stock | 14,416 | $0.01 | $144.16 |
DisclosureSEC source: 0001209191-16-095841 · doc4.xml · nonDerivative · entry 1 Chodakewitz Jeffrey · CIK 0001610876 · EVP GMDA, CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,978 F1 · shares: Restricted stock unit award that vests in three equal installments on 2/10/2017, 2/10/2018 and 2/10/2019. Read SEC document |
| February 02, 2016 Filed Feb 4, 2016 23:52 UTC |
LEIDEN JEFFREY MDirector · CEO & President
|
GrantStock Option (Right to Buy) · Derivative | 107,276 | $0.00 Strike: $91.05 | $0.00 |
DisclosureSEC source: 0001209191-16-095842 · doc4.xml · derivative · entry 7 LEIDEN JEFFREY M · CIK 0001242825 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,276 Underlying: Common Stock · 107,276 shares Expires 2026-02-01 F8 · derivative.exercise_date: The option vests in 16 quarterly installments from 02/02/2016. Read SEC document |
| February 02, 2016 Filed Feb 4, 2016 23:52 UTC |
LEIDEN JEFFREY MDirector · CEO & President
|
GrantCommon Stock | 53,817 | $0.01 | $538.17 |
DisclosureSEC source: 0001209191-16-095842 · doc4.xml · nonDerivative · entry 1 LEIDEN JEFFREY M · CIK 0001242825 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 271,719 F1 · shares: Restricted stock unit award that vests in three equal installments on 2/10/2017, 2/10/2018 and 2/10/2019. Read SEC document |
| February 02, 2016 Filed Feb 4, 2016 23:52 UTC |
Sachdev AmitEVP, Policy, Access & Value
|
GrantStock Option (Right to Buy) · Derivative | 34,482 | $0.00 Strike: $91.05 | $0.00 |
DisclosureSEC source: 0001209191-16-095843 · doc4.xml · derivative · entry 7 Sachdev Amit · CIK 0001406338 · EVP, Policy, Access & Value 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,482 Underlying: Common Stock · 34,482 shares Expires 2026-02-01 F8 · derivative.exercise_date: The option vests in 16 quarterly installments from 02/02/2016. Read SEC document |
| February 02, 2016 Filed Feb 4, 2016 23:52 UTC |
Sachdev AmitEVP, Policy, Access & Value
|
GrantCommon Stock | 17,299 | $0.01 | $172.99 |
DisclosureSEC source: 0001209191-16-095843 · doc4.xml · nonDerivative · entry 1 Sachdev Amit · CIK 0001406338 · EVP, Policy, Access & Value 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,262 F1 · shares: Restricted stock unit award that vests in three equal installments on 2/10/2017, 2/10/2018 and 2/10/2019. Read SEC document |
| February 02, 2016 Filed Feb 4, 2016 23:53 UTC |
Silva Paul MSVP & Corp Controller
|
GrantStock Option (Right to Buy) · Derivative | 20,625 | $0.00 Strike: $91.05 | $0.00 |
DisclosureSEC source: 0001209191-16-095844 · doc4.xml · derivative · entry 7 Silva Paul M · CIK 0001446372 · SVP & Corp Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,625 Underlying: Common Stock · 20,625 shares Expires 2026-02-01 F8 · derivative.exercise_date: The option vests in 16 quarterly installments from 02/02/2016. Read SEC document |
| February 02, 2016 Filed Feb 4, 2016 23:53 UTC |
Silva Paul MSVP & Corp Controller
|
GrantCommon Stock | 6,875 | $0.01 | $68.75 |
DisclosureSEC source: 0001209191-16-095844 · doc4.xml · nonDerivative · entry 1 Silva Paul M · CIK 0001446372 · SVP & Corp Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,812 F1 · shares: Restricted stock grant vesting on 2/2/2019, subject to acceleration if certain financial and/or business metrics are achieved. Read SEC document |
| February 02, 2016 Filed Feb 4, 2016 23:54 UTC |
SMITH IAN FEVP & CFO
|
GrantStock Option (Right to Buy) · Derivative | 34,482 | $0.00 Strike: $91.05 | $0.00 |
DisclosureSEC source: 0001209191-16-095845 · doc4.xml · derivative · entry 7 SMITH IAN F · CIK 0001197032 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,482 Underlying: Common Stock · 34,482 shares Expires 2016-02-01 F8 · derivative.exercise_date: The option vests in 16 quarterly installments from 02/02/2016. Read SEC document |
| February 02, 2016 Filed Feb 4, 2016 23:54 UTC |
SMITH IAN FEVP & CFO
|
GrantCommon Stock | 17,299 | $0.01 | $172.99 |
DisclosureSEC source: 0001209191-16-095845 · doc4.xml · nonDerivative · entry 1 SMITH IAN F · CIK 0001197032 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,083 F1 · shares: Restricted stock unit award that vests in three equal installments on 2/10/2017, 2/10/2018 and 2/10/2019. Read SEC document |
| January 27, 2016 Filed Jan 29, 2016 21:08 UTC |
BOGER JOSHUA SDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 11,200 | $0.00 Strike: $35.64 | $0.00 |
DisclosureSEC source: 0001209191-16-094138 · doc4.xml · derivative · entry 10 BOGER JOSHUA S · CIK 0001197023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,200 shares Expires 2016-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: Fully vested. Read SEC document |
| January 27, 2016 Filed Jan 29, 2016 21:08 UTC |
BOGER JOSHUA SDirector
|
SaleCommon Stock | 100 | $95.71 | $9,571.00 |
DisclosureSEC source: 0001209191-16-094138 · doc4.xml · nonDerivative · entry 7 BOGER JOSHUA S · CIK 0001197023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 265,284 F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1. Read SEC document |
| January 27, 2016 Filed Jan 29, 2016 21:08 UTC |
BOGER JOSHUA SDirector
|
SaleCommon Stock | 2,100 | $94.94 | $199,374.00 |
DisclosureSEC source: 0001209191-16-094138 · doc4.xml · nonDerivative · entry 6 BOGER JOSHUA S · CIK 0001197023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 265,384 F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1. F3 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F7 · price: Open market sales reported on this line occurred at a weighted average price of $94.94 (range $94.65 to $95.31). Read SEC document |
| January 27, 2016 Filed Jan 29, 2016 21:08 UTC |
BOGER JOSHUA SDirector
|
SaleCommon Stock | 2,600 | $94.10 | $244,660.00 |
DisclosureSEC source: 0001209191-16-094138 · doc4.xml · nonDerivative · entry 5 BOGER JOSHUA S · CIK 0001197023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 267,484 F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1. F3 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F6 · price: Open market sales reported on this line occurred at a weighted average price of $94.10 (range $93.63 to $94.53). Read SEC document |
| January 27, 2016 Filed Jan 29, 2016 21:08 UTC |
BOGER JOSHUA SDirector
|
SaleCommon Stock | 2,400 | $93.00 | $223,200.00 |
DisclosureSEC source: 0001209191-16-094138 · doc4.xml · nonDerivative · entry 4 BOGER JOSHUA S · CIK 0001197023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 270,084 F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1. F3 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F5 · price: Open market sales reported on this line occurred at a weighted average price of $93.00 (range $92.61 to $93.51). Read SEC document |
| January 27, 2016 Filed Jan 29, 2016 21:08 UTC |
BOGER JOSHUA SDirector
|
SaleCommon Stock | 3,300 | $92.04 | $303,732.00 |
DisclosureSEC source: 0001209191-16-094138 · doc4.xml · nonDerivative · entry 3 BOGER JOSHUA S · CIK 0001197023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 272,484 F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1. F3 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F4 · price: Open market sales reported on this line occurred at a weighted average price of $92.04 (range $91.61 to $92.60). Read SEC document |
| January 27, 2016 Filed Jan 29, 2016 21:08 UTC |
BOGER JOSHUA SDirector
|
SaleCommon Stock | 700 | $90.70 | $63,490.00 |
DisclosureSEC source: 0001209191-16-094138 · doc4.xml · nonDerivative · entry 2 BOGER JOSHUA S · CIK 0001197023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 275,784 F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $90.70 (range $90.57 to $91.23). F3 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.